Results 111 to 120 of about 461,308 (260)
Phorbol ester induced ex vivo expansion of rigorously-defined phenotypic but not functional human cord blood hematopoietic stem cells: a cautionary tale demonstrating that phenotype does not always recapitulate stem cell function [PDF]
, 2019 Broxmeyer, Hal E., Chen, Yandan, Guo, Bin, Huang, Xinxin, Jiang, Rongzhen, Liu, Sheng, Teng, Yincheng, Wan, Jun, Yao, Chunxu +8 morecore +1 more sourceAllogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel.
Blood, 2017 T. D. Witte, D. Bowen, M. Robin, L. Malcovati, D. Niederwieser, I. Yakoub-Agha, G. Mufti, P. Fenaux, G. Sanz, R. Martino, E. Alessandrino, F. Onida, A. Symeonidis, J. Passweg, G. Kobbe, A. Ganser, U. Platzbecker, J. Finke, M. Gelder, A. A. Loosdrecht, P. Ljungman, R. Stauder, L. Volin, H. Deeg, C. Cutler, W. Saber, R. Champlin, S. Giralt, C. Anasetti, N. Kröger +29 moresemanticscholar +1 more sourceThe INSPECTOR study: enhanced feasibility for clinical translation of a multi‐cancer early detection method based on enzyme‐assisted high signal‐to‐noise ratio sequencing of methylated circulating tumor DNA
Cancer Communications, EarlyView.Abstract Background
Blood‐based cell‐free DNA (cfDNA) methylation testing has emerged as a promising approach for multi‐cancer early detection (MCED), holding the potential to improve cancer survival rates. However, traditional bisulfite‐based methods often encounter sensitivity limitations in detecting early‐stage malignancies or certain cancer types. Hui‐Yan Luo, Wei Wei, Pansong Li, Qi‐Hua Zhang, Zhipeng Zhou, Liang Cui, Yong‐Bin Lin, Hong Yang, Xianyu Zhong, Qingfeng Liu, Han Yang, Kong‐Jia Luo, Hai‐Bo Qiu, Shu‐Qiang Yuan, Yuan‐Fang Li, Zhi‐Wei Zhou, Xiao‐Jun Lin, Bo‐Kang Cui, Rong‐Xin Zhang, Wen‐Hua Fan, He Huang, Chun‐Yan Lan, Jun‐Dong Li, Zhi‐Qiang Wang, Bin‐Kui Li, Rong‐Ping Guo, Jun Tang, Xin Huang, Mian Xi, Yuying Liu, Chuanbo Xie, Shi Chen, Zhi‐Hu Li, Yu‐Hua Liu, Xiao‐Ting Zhang, Qiang Zeng, Xin Yi, Rui‐Hua Xu +37 morewiley +1 more sourceIncreased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice
Science Translational Medicine, 2016 Y. Shono, Melissa Docampo, J. Peled, S. M. Perobelli, E. Velardi, J. Tsai, Ann E. Slingerland, O. Smith, L. Young, J. Gupta, Sophia R Lieberman, Hillary V. Jay, Katya Ahr, Kori A. Porosnicu Rodriguez, Ke Xu, Marco Calarfiore, Hendrik Poeck, S. Caballero, S. Devlin, Franck Rapaport, J. Dudakov, A. Hanash, B. Gyurkocza, G. Murphy, C. Gomes, Chen Liu, Eli Moss, S. Falconer, A. Bhatt, Y. Taur, E. Pamer, M. V. D. van den Brink, R. Jenq +32 moresemanticscholar +1 more sourceEffect of Inpatient Palliative Care on Quality of Life 2 Weeks After Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial.
Journal of the American Medical Association (JAMA), 2016 A. El-Jawahri, T. Leblanc, Harry Vandusen, L. Traeger, J. Greer, W. Pirl, V. Jackson, Jason Telles, Alison M. Rhodes, T. Spitzer, S. Mcafee, Yi-Bin Chen, Stephanie S Lee, J. Temel +13 moresemanticscholar +1 more sourcePopulation Pharmacokinetics and Exposure–Response Analyses of Momelotinib, Its Active Metabolite (M21), and Total Active Moiety in Myelofibrosis
Clinical Pharmacology &Therapeutics, EarlyView.Momelotinib, a Janus kinase (JAK) 1/JAK2/activin A receptor type 1 inhibitor, is approved for the treatment of myelofibrosis with anemia. These analyses characterized the population pharmacokinetics of momelotinib and its active metabolite M21 following administration of the commercial tablet formulation in patients with myelofibrosis from phase II/III Benjamin Rich, Meenakshi Srinivasan, Yu Liu Ho, Sandra A.G. Visser, Geraldine Ferron‐Brady, Georgios Vlasakakis +5 morewiley +1 more sourceCystatin C‐based eGFR better predicts renal vancomycin clearance than creatinine‐based eGFR in patients with allogeneic stem cell transplantation
Clinical Pharmacology &Therapeutics, EarlyView.Knowledge of the glomerular filtration rate (GFR) is mandatory when dosing renally eliminated drugs such as vancomycin. In clinical practice, different biomarkers and various equations are used to estimate GFR (eGFR), resulting in varying estimates.Eva‐Maria A. Wansing, Sebastian G. Wicha, Peter Bannas, Alexander Heitkamp, Adrin Dadkhah, Nicolaus M. Kröger, Isabel Molwitz, Claudia Langebrake +7 morewiley +1 more sourceTransendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial
ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.Abstract Aims
The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of
the EXCELLENT Trial Investigators +17 morewiley +1 more sourceThe effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation.
Blood, 2014 Y. Taur, R. Jenq, M. Perales, E. Littmann, S. Morjaria, Lilan Ling, Daniel No, Asia Gobourne, A. Viale, P. Dahi, D. Ponce, J. Barker, S. Giralt, M. V. D. van den Brink, E. Pamer +14 moresemanticscholar +1 more source